Christopher Dye
Cited by
Cited by
Global Tuberculosis Control
World Health Organization
Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country
C Dye, S Scheele, V Pathania, MC Raviglione
Jama 282 (7), 677-686, 1999
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic
EL Corbett, CJ Watt, N Walker, D Maher, BG Williams, MC Raviglione, ...
Archives of internal medicine 163 (9), 1009-1021, 2003
The effect of human mobility and control measures on the COVID-19 epidemic in China
MUG Kraemer, CH Yang, B Gutierrez, CH Wu, B Klein, DM Pigott, ...
Science 368 (6490), 493-497, 2020
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
RM Granich, CF Gilks, C Dye, KM De Cock, BG Williams
The Lancet 373 (9657), 48-57, 2009
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China
H Tian, Y Liu, Y Li, CH Wu, B Chen, MUG Kraemer, B Li, J Cai, B Xu, ...
Science 368 (6491), 638-642, 2020
Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections
WHO Ebola Response Team
New England Journal of Medicine 371 (16), 1481-1495, 2014
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil
NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ...
Science 372 (6544), 815-821, 2021
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness
BB Trunz, PEM Fine, C Dye
The Lancet 367 (9517), 1173-1180, 2006
Drivers of tuberculosis epidemics: the role of risk factors and social determinants
K Lönnroth, E Jaramillo, BG Williams, C Dye, M Raviglione
Social science & medicine 68 (12), 2240-2246, 2009
Heterogeneities in the transmission of infectious agents: implications for the design of control programs
MEJ Woolhouse, C Dye, JF Etard, T Smith, JD Charlwood, GP Garnett, ...
Proceedings of the National Academy of Sciences 94 (1), 338-342, 1997
Estimates of world-wide distribution of child deaths from acute respiratory infections
BG Williams, E Gouws, C Boschi-Pinto, J Bryce, C Dye
The Lancet infectious diseases 2 (1), 25-32, 2002
Global epidemiology of tuberculosis
C Dye
The Lancet 367 (9514), 938-940, 2006
Global trends in resistance to antituberculosis drugs
MA Espinal, A Laszlo, L Simonsen, F Boulahbal, SJ Kim, A Reniero, ...
New England Journal of Medicine 344 (17), 1294-1303, 2001
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
EC Sabino, LF Buss, MPS Carvalho, CA Prete, MAE Crispim, NA Fraiji, ...
The Lancet 397 (10273), 452-455, 2021
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries
MA Espinal, SJ Kim, PG Suarez, KM Kam, AG Khomenko, GB Migliori, ...
Jama 283 (19), 2537-2545, 2000
Global incidence of multidrug-resistant tuberculosis
M Zignol, MS Hosseini, A Wright, CL Weezenbeek, P Nunn, CJ Watt, ...
The Journal of infectious diseases 194 (4), 479-485, 2006
The population dynamics and control of tuberculosis
C Dye, BG Williams
Science 328 (5980), 856-861, 2010
Alcohol use as a risk factor for tuberculosis–a systematic review
K Lönnroth, BG Williams, S Stadlin, E Jaramillo, C Dye
BMC public health 8, 1-12, 2008
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
C Dye, CJ Watt, DM Bleed, SM Hosseini, MC Raviglione
Jama 293 (22), 2767-2775, 2005
The system can't perform the operation now. Try again later.
Articles 1–20